Prediction of Response to IUCD Associated Menorrhagia Using Doppler
Assessment of Efficacy of Uterine Artery Doppler in Predicting the Response to Mefenamic Acid During Treatment of Women With IUCD Associated Menorrhagia
1 other identifier
interventional
156
1 country
1
Brief Summary
Studying the efficacy of uterine artery doppler in predicting response to mefenamic acid in women having IUCD associated menorrhagia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedFirst Submitted
Initial submission to the registry
December 27, 2018
CompletedFirst Posted
Study publicly available on registry
January 7, 2019
CompletedJanuary 7, 2019
January 1, 2019
1 year
December 27, 2018
January 3, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Resistance index and Pulsitality index (Predicting the response to IUCD associated menorrhagia)
Base line uterine artery doppler is done to the patient complaining of IUCD related menorrhagia prior to treatment , parameters of doppler are: resistance index and pulsitality index, then the patient takes mefenamic acid tablets 500 mg three times daily for five days, assessment of response whether the patient is responder or not is done using pictorial blood loss assessment chart then base line doppler parameters in responders and non responders are compared to correlate the response to base line doppler parameters
1 year
Study Arms (1)
Single arm clinical trial
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- women in chile bearing period (age 20-35 yrs ) with history of regular menstrual cycle presenting with recent onset of more then three months menorrhagia after IUCD "copper T 380 A" insertion
You may not qualify if:
- history of bleeding tendency
- history of abnormal uterine bleeding due to other causes
- history of active liver disease
- history of antiplatelet or anticoagulant intake in the last month
- history of thyroid disease
- history of endometritis
- history of allergy to NSAIDs
- Adenomyosis
- women having contraindications to use NSAIDs e.g. peptic ulcer
- Insulin dependant diabetes mellitus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AinshamsU
Cairo, Abbaseya, 11511, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yasmine Es Ismail, Bachelor
Ain Shams University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 27, 2018
First Posted
January 7, 2019
Study Start
May 1, 2017
Primary Completion
May 1, 2018
Study Completion
May 1, 2018
Last Updated
January 7, 2019
Record last verified: 2019-01